Epirubicin Hydrochloride
56390-09-1COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1.ClMWWSFMDVAYGXBV-FGBSZODSSA-NEpirubicin hydrochloride is an anthracycline. It has a role as an antineoplastic agent.
Breast Feeding; Lactation; Milk, Human; Antineoplastic Agents; Anthracyclines; Antibiotics, Antineoplastic; Topoisomerase II Inhibitors
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Danger
H302 (99.2%): Harmful if swallowed [Warning Acute toxicity, oral]
P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 130 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
5,12-Naphthacenedione, 10-(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Drug Induced Liver Injury Rank (DILIrank 2.0)
Epirubicin hydrochloride
Ambiguous-DILI-concern
3
Warnings & precautions
DOI:10.1016/j.drudis.2016.02.015
EPIRUBICIN HYDROCHLORIDE
Anthracycline Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]; Anthracyclines [CS]
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.
用途アントラサイクリン系抗生物 質です。がん細胞の DNA と結合し、DNA ポ リメラーゼ、RNA ポリメラーゼ反応を阻害す ることにより核酸の生合成を阻害し、細胞分 裂抑制作用を示します。
用途アントラサイクリン系抗生物 質です。ドキソルビシン塩酸塩の 4' 位 OH 基 が反転した立体異性体です。DNA ポリメラー ゼ、RNA ポリメラーゼ反応を阻害することに より核酸の生合成を阻害し、細胞分裂を抑制 します。
説明Epirubicin hydrochloride is an antitumor antibiotic which is epimeric with doxorubicin a t the 4’-position of the amino sugar moiety. It has shown utility in the treatment of mammary, gastric, colorectal, pulmonary and ovarian carcinomas, as well as malignant lymphoma and melanoma and soft tissue sarcoma. It is reported to be less sardiotoxic than doxorubicin.
使用Used as an antineoplastic
読み込み中…
56390-09-1DTXSID50860297CHEMBL1200981CHEBI:232543化学的特性Orange-Red Crystalline Solid